2008 Conference Publication Chronic kidney disease management: a multidisciplinary clinic modelFrazier, J., Blizzard, S., Douglas, B., Oliver, V., Johnson, D., Hawley, C., Campbell, S., Mudge, D. and Isbel, N. (2008). Chronic kidney disease management: a multidisciplinary clinic model. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Richmond, VIC, Australia: Wiley-Blackwell. |
2008 Conference Publication Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markersGobe, G. C., Johnson, D. W., Li, J., Pat, B. K., Percy, C. J. and Rajandram, R. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x |
2008 Conference Publication Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Carlton, Australia: Blackwell. doi: 10.1111/j.1440-1797.2008.001013.x |
2008 Conference Publication Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesityPercy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. OXFORD: BLACKWELL PUBLISHING. |
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
2008 Conference Publication Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Hoboken, NJ, United States: Wiley-Blackwell. |
2008 Conference Publication Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responsesGobe, Glenda C., Bennett, Nigel, Patel, Jatin, Colditz, Paul, Vesey, David A. and Johnson, David W. (2008). Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses. Renal Week 2008: American Society of Nephrology Annual Meeting, Philadephia, USA, 14 - 19 November, 2008. Washington, D. C., USA: American Society of Nephrology. |
2008 Conference Publication Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantationBrooks, E. K., Johnson, D. W., Staatz, Christine E., Taylor, P. J. and Tett, Susan E. (2008). Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation. Australian Health and Medical Research Congress (AHMRC) 2008, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC. |
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
2008 Conference Publication Implementation of the routine reporting of eGFR in Australia and New ZealandJones, Graham R. D., Mathew, Timothy, Johnson, David and Peake, Michael (2008). Implementation of the routine reporting of eGFR in Australia and New Zealand. 11th Bergmeyer Conference, Eibsee, 2008. Taylor & Francis. doi: 10.1080/00365510802144953 |
2008 Conference Publication Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x |
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsMollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology. |
2007 Conference Publication The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD). 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
2007 Conference Publication Molecular and cellular changes associated with age-related chronic kidney diseasePercy, C., Brown, L., Power, D., Johnson, D. W. and Gobe, G. C. (2007). Molecular and cellular changes associated with age-related chronic kidney disease. International Society of Nephrology's World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007. |
2007 Conference Publication Erythropoietin: Novel applications beyond anaemia treatmentVesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007. |
2007 Conference Publication What is the optimal fat mass in peritoneal dialysis patients?Johnson, David W. (2007). What is the optimal fat mass in peritoneal dialysis patients?. 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25 - 29 August, 2006. Milton, Ontario: Multimed. |
2007 Conference Publication Live donor characteristics over the last 15 yearsKaisar, M. O., Campbell, S., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Isbel, N. (2007). Live donor characteristics over the last 15 years. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
2007 Conference Publication Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markersRajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers. 46th ASMR National Scientific Conference, Katoomba, N.S.W., Australia, 11-13 November 2007. |
2007 Conference Publication Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipientKaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
2007 Conference Publication Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant PatientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x |